| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 6/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
StemCell Institute Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,657.00 |
| 52 Week High | JP¥2,776.00 |
| 52 Week Low | JP¥1,213.00 |
| Beta | 0.69 |
| 11 Month Change | 0.55% |
| 3 Month Change | -1.02% |
| 1 Year Change | -35.25% |
| 33 Year Change | -27.96% |
| 5 Year Change | n/a |
| Change since IPO | -19.76% |
Recent News & Updates
Shareholder Returns
| 7096 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 2.3% | 2.8% | 2.9% |
| 1Y | -35.2% | 4.7% | 14.9% |
Return vs Industry: 7096 underperformed the JP Healthcare industry which returned 4.7% over the past year.
Return vs Market: 7096 underperformed the JP Market which returned 14.9% over the past year.
Price Volatility
| 7096 volatility | |
|---|---|
| 7096 Average Weekly Movement | 9.8% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in JP Market | 10.1% |
| 10% least volatile stocks in JP Market | 3.4% |
Stable Share Price: 7096's share price has been volatile over the past 3 months.
Volatility Over Time: 7096's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 98 | Takafumi Shimizu | www.stemcell.co.jp |
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan.
StemCell Institute Inc. Fundamentals Summary
| 7096 fundamental statistics | |
|---|---|
| Market cap | JP¥16.98b |
| Earnings (TTM) | JP¥413.00m |
| Revenue (TTM) | JP¥2.58b |
41.1x
P/E Ratio6.6x
P/S RatioIs 7096 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7096 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.58b |
| Cost of Revenue | JP¥939.00m |
| Gross Profit | JP¥1.64b |
| Other Expenses | JP¥1.23b |
| Earnings | JP¥413.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 40.31 |
| Gross Margin | 63.63% |
| Net Profit Margin | 16.00% |
| Debt/Equity Ratio | 0% |
How did 7096 perform over the long term?
See historical performance and comparison